Rimonabant--a new weapon in the war on obesity
- PMID: 17087852
- DOI: 10.1007/s11906-006-0019-6
Rimonabant--a new weapon in the war on obesity
Comment on
-
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.JAMA. 2006 Feb 15;295(7):761-75. doi: 10.1001/jama.295.7.761. JAMA. 2006. PMID: 16478899 Clinical Trial.